CIPO Patents = 1

EPO Patents = 1

Forward Citations = 16

Loading Chart...

7 inventors (with patents filed for the assignee):

Adam Ezra Cohen (5 out of 25 patents)

Joel Kralj (4 out of 10 patents)

Evangelos Kiskinis (3 out of 6 patents)

4. Kevin C Eggan (3 out of 7 patents)

5. Christopher Werley (2 out of 8 patents)

6. Steven Charles Wasserman (1 out of 6 patents)

7. Graham Dempsey (1 out of 1 patent)

8. Adam Cohen (0 patent)

5 patents: Sort by Forward Citations

1. 10613079 - Diagnostic methods for neural disorders (2020-04-07),

2. 10288863 - Optogenetics microscope (2019-05-14),

3. 10107796 - Diagnostic methods for neural disorders (2018-10-23),

4. 10048275 - Cardiotoxicity screening methods (2018-08-14),

5. 9594075 - Diagnostic methods for neural disorders (2017-03-14),

Q-State Biosciences, Inc. is a biotechnology company focused on developing novel treatments for neurological disorders. With a mission to pioneer the next generation of precision medicines, Q-State leverages cutting-edge technologies to better understand the biology of the brain and develop innovative therapies. Through their innovative approach, Q-State aims to bring transformative therapies to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#336 in Cambridge, MA

#2,815 in Massachusetts

#50,237 in US

Cambridge, MA, United States of America

Q-state Biosciences, Inc.

Forward Citations = 16

7 inventors:

Adam Ezra Cohen (5 out of 25 patents)

Joel Kralj (4 out of 10 patents)

Evangelos Kiskinis (3 out of 6 patents)

4. Kevin C Eggan (3 out of 7 patents)

5. Christopher Werley (2 out of 8 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com